Slingshot members are tracking this event:

AstraZeneca and Astellas working with FibroGen in studies treating CKD anemia, with NDA expected in 2018

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
FGEN Community voting in process
AZN Community voting in process
ALPMY Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 01, 2018
Occurred Source:
Related Keywords Nda, Ckd Anemia, Fda